GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 15 - 85 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Clarus Therapeutics Holdings, Inc. Stock and on which exchange is it traded?
The symbol for Clarus Therapeutics Holdings, Inc. is CRXT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Clarus Therapeutics Holdings, Inc. Stock?
Clarus Therapeutics Holdings, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Clarus Therapeutics Holdings, Inc. Stock?
Clarus Therapeutics Holdings, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Clarus Therapeutics Holdings, Inc. Stock.

What's the current price of Clarus Therapeutics Holdings, Inc. Stock?
As of the end of day on the 2023-02-07, the price of an Clarus Therapeutics Holdings, Inc. (CRXT) share was $0.0291.

What is the 52-week high and low for Clarus Therapeutics Holdings, Inc. Stock?
The 52-week high for Clarus Therapeutics Holdings, Inc. Stock is $3.94 and the 52-week low is $0.0150.
Click to get the best stock tips daily for free!

About Clarus Therapeutics Holdings, Inc.

Clarus Therapeutics Holdings. Clarus Therapeutics Holdings, Inc., a pharmaceutical company, focuses on the development and commercialization of oral testosterone replacement therapy in the United States. It offers JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company has a licensing agreement with HavaH Therapeutics for product to treat androgen therapies for inflammatory breast disease and certain forms of breast cancer; a... CRXT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT